PROFESSIONAL EDITION

The largest community of pharma leaders

FDA Broadly Supports Oragenics’ Pre-IND Development Program for its SARS-CoV-2 Vaccine

TAMPA, Fla.–(BUSINESS WIRE)–FDA Broadly Supports Oragenics’ Pre-IND Development Program for its SARS-CoV-2 Vaccine

Source

Recent Articles